Suppr超能文献

乌干达西尼罗河地区一系列伯基特淋巴瘤中的爱泼斯坦-巴尔病毒标志物

Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda.

作者信息

Geser A, Lenoir G M, Anvret M, Bornkamm G, Klein G, Williams E H, Wright D H, De-The G

出版信息

Eur J Cancer Clin Oncol. 1983 Oct;19(10):1393-404. doi: 10.1016/0277-5379(93)90009-t.

Abstract

In an epidemiological survey in the West Nile District of Uganda, 70 pathologically confirmed BL cases were detected over a 5-yr period; this corresponded to an annual incidence rate of 1.6 per 100,000 general population or about 5 per 100,000 children in the age group 5-14 yr. Of the confirmed cases which were examined by EBV/DNA molecular hybridization, 96% were found to contain an average of 38 EBV genome equivalents per tumour cell, whereas none of the examined unconfirmed cases did. Duplicate hybridization assays in two laboratories were in close agreement. Serological testing showed that 91% of the confirmed BL cases had elevated EBV/VCA titres (greater than or equal to 160) and 64% were EA(D)-positive (greater than or equal to 10). Most of the cases with high EBV/genome content had high VCA titres, but there was a poor correlation between the two parameters among all cases. This study confirms that in high BL incidence areas the association between EBV and this lymphoma is almost constant, whereas it is exceptional in low-incidence areas. This further supports the aetiological implication of EBV in the endemicity of this tumor in equatorial Africa.

摘要

在乌干达西尼罗河地区的一项流行病学调查中,在5年期间检测到70例经病理确诊的伯基特淋巴瘤(BL)病例;这相当于每10万普通人群的年发病率为1.6例,或5至14岁年龄组中每10万儿童约5例。在通过EBV/DNA分子杂交检测的确诊病例中,96%被发现每个肿瘤细胞平均含有38个EBV基因组当量,而所检测的未确诊病例均未发现。两个实验室的重复杂交试验结果高度一致。血清学检测显示,91%的确诊BL病例EBV/VCA滴度升高(大于或等于160),64%的病例EA(D)呈阳性(大于或等于10)。大多数EBV/基因组含量高的病例VCA滴度也高,但在所有病例中这两个参数之间的相关性较差。这项研究证实,在BL高发地区,EBV与这种淋巴瘤之间的关联几乎是恒定的,而在低发地区则很罕见。这进一步支持了EBV在赤道非洲这种肿瘤的地方性流行中的病因学意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验